Clinical Takeaway In this phase 3 trial of 820 adults with chronic low back pain, the full-spectrum cannabis extract VER-01 was evaluated against placebo over 12 weeks with extended follow-up lasting up...
endocannabinoid system clinical research: Phase 3 Cannabis Trial
Clinical Takeaway In this phase 3 trial of 820 adults with chronic low back pain, the full-spectrum cannabis extract VER-01 was evaluated over a 12-week double-blind treatment period with extended follow-up reaching...
endocannabinoid system clinical research: Phase 3 Cannabis Trial
Clinical Takeaway In this phase 3 trial of 820 adults with chronic low back pain, the full-spectrum cannabis extract VER-01 was evaluated over a 12-week double-blind treatment period followed by longer-term open-label...
endocannabinoid system clinical research: Cannabis for Back Pain
Clinical Takeaway In this phase 3 trial of 820 adults with chronic low back pain, the full-spectrum cannabis extract VER-01 was evaluated against placebo over a 12-week double-blind period with longer-term follow-up...
endocannabinoid system clinical research: Cannabis for Back Pain
Clinical Takeaway In this phase 3 trial of 820 adults, the full-spectrum cannabis extract VER-01 was evaluated against placebo over 12 weeks for chronic low back pain, a condition affecting more than...
endocannabinoid system clinical research: Phase 3 Cannabis Trial
Clinical Takeaway In this phase 3 trial of 820 adults with chronic low back pain, the full-spectrum cannabis extract VER-01 was evaluated against placebo over 12 weeks with extended follow-up up to...
`Endocannabinoid System RCT: Cannabis for Chronic Back Pain`
Clinical Takeaway In this phase 3 randomized controlled trial of 820 adults with chronic low back pain, VER-01, a full-spectrum cannabis extract, was evaluated against placebo over 12 weeks with extended follow-up...
endocannabinoid system clinical research: Cannabis for Back Pain
Clinical Takeaway In a rigorous phase 3 randomized controlled trial of 820 adults, the full-spectrum cannabis extract VER-01 was evaluated against placebo over 12 weeks for chronic low back pain, with follow-up...
`Cannabinoid Clinical Trials: Cannabis for Chronic Back Pain`
Clinical Takeaway In this Phase 3 trial of 820 adults with chronic low back pain, a full-spectrum cannabis extract (VER-01) was evaluated over a 12-week blinded treatment period with extended follow-up reaching...
endocannabinoid system clinical research: Phase 3 Cannabis Trial
Clinical Takeaway In this phase 3 randomized controlled trial of 820 adults, a full-spectrum cannabis extract (VER-01) was evaluated against placebo for chronic low back pain over a 12-week double-blind period with...